Ge Long Hui·2025-10-10 09:35Core Viewpoint - Tiger Medical (03347.HK) announced the conditional sale of all issued shares of Shanghai Guanhua Medical Technology Co., Ltd. for a total consideration of RMB 270 million, which is expected to enhance operational efficiency and resource allocation within the group [1] Group 1: Transaction Details - The sale agreement is between Tiger Medical and its wholly-owned subsidiary, Jiaxing Xinge Medical Technology Co., Ltd., and the buyer is Fangda Pharmaceutical Technology (Shanghai) Co., Ltd., a wholly-owned subsidiary of Fangda Holdings [1] - The total consideration for the transaction is RMB 270 million [1] Group 2: Strategic Implications - The board believes that the sale will allow the group to optimize resource allocation and enhance operational efficiency through internal resource integration [1] - As Fangda Holdings is also a subsidiary of the group, the transaction will facilitate better coordination of business functions and promote synergy within the overall group structure [1] - Integrating the target group's business under Fangda Holdings is expected to achieve centralized management and simplify decision-making processes, thereby improving cost-effectiveness and operational focus [1]